Be Ready to Handle Rxs for the New COPD Drug, Yupelri
Rx Yupelri (yoo-PEL-ree) will be a new nebulized med for COPD.
Think of Yupelri (revefenacin) as an alternative to Lonhala Magnair (glycopyrrolate). They're both long-acting "anticholinergics" given via a nebulizer...and each costs about $1,000 per month.
But there are a few differences that will give Yupelri an edge.